当前位置: X-MOL 学术Blood › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Cardiovascular adverse events of ibrutinib
Blood ( IF 20.3 ) Pub Date : 2019-11-28 , DOI: 10.1182/blood.2019002805
Inhye E. Ahn

In this issue of Blood, Dickerson et al report on the increased incidence and worsening severity of hypertension and its association with cardiovascular outcomes in 562 patients treated with ibrutinib for B-cell malignancies.

中文翻译:

依鲁替尼的心血管不良事件

在本期血液中,Dickerson 等人报告了 562 名接受依鲁替尼治疗 B 细胞恶性肿瘤的患者的高血压发病率增加和严重程度恶化及其与心血管结局的相关性。
更新日期:2019-11-28
down
wechat
bug